We identified four HRQOL LPs at 5 and 25 months. LP1 had the poorest HRQOL and LP4 the best. Membership in the poorest profile at 5 months was associated with younger age aOR 0.95; 0.93-0.96, White race aOR 1.48; 1.25-1.65, being unmarried aOR 1.50; 1.28-1.65 and having public aOR 3.09; 1.96-4.83 or no insurance aOR 6.51; 2.12-20.10. At 25 months, Black race aOR 1.75; 1.18-1.82 was associated with the poorest profile membership. Black race and smoking were predictors of deteriorating to a worse profile from 5 to 25 months. Conclusions Our results suggest patient-level characteristics including age at diagnosis and race may identify women at risk for experiencing poor HRQOL patterns. If women are identified and offered targeted HRQOL support, we may see improvements in long-term HRQOL and better breast cancer outcomes.
Introduction
Health-related quality of life (HRQOL) is a multidimensional concept representing an individual's perception of well-being, including spiritual, functional, physical, emotional, and social well-being [1, 2] . Women with breast cancer (BC) in the United States experience HRQOL decrements following diagnosis, during active treatment, and through BC survivorship [3] [4] [5] . HRQOL concerns include fear of BC recurrence or death, lymphedema, fatigue, early menopause, and difficulty returning to work [1, 3, 6, 7] . Poorly managed HRQOL is associated with increased mortality risk [8] . Incorporating HRQOL assessments into
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cancer care management may help ensure more patientcentered care and improve BC outcomes [9] .
HRQOL is often presented as a single global score, which limits understanding of nuances in HRQOL and the utility of such scores as screening tools for poor health outcomes. For example, a woman may experience optimal physical well-being throughout BC treatment, but suffer significant decrements in psychosocial well-being. Thus, by focusing only on a single, overall score, a clinician may inadvertently overlook decrements in their patients' HRQOL [5] .
Although many studies continue to use global indicators of HRQOL, domain-specific measures are also often used to represent the multidimensional nature of HRQOL. However, traditional methods to analyzing differences or changes in domain-specific HRQOL, which compare means and standard deviations, are criticized for not representing heterogeneity in HRQOL experiences [10] . Examining mean differences in HRQOL scores alone may lead us to erroneous conclusions regarding outliers or subgroups [10] . That is, small differences or patterns may be masked and subgroups of women who experience improvements or decrements may be missed [10] . While mean differences in HRQOL scores reflect group-level HRQOL effects of diagnosis or treatment, these overall scores may conceal subgroups of patients experiencing unusually large decrements in a particular domain, or decrements across multiple domains. Such patients may benefit from more targeted HRQOL intervention.
Cluster analysis has been used to identify subgroups of patients at increased risk of poor health outcomes with the expectation of tailoring treatment choices to patientspecific needs [11] [12] [13] [14] [15] . Previous studies found that meaningful subgroups of cancer patients could be identified and clinical interventions may have seen better outcomes if an individual's HRQOL had been considered in care decisions [11, 13] . For example, women who were identified to be in emotionally unhealthy clusters could have been supported with psychotherapy sessions following diagnosis to ameliorate the emotional impacts of BC and to help them cope with diagnosis and treatment [11, 13, 16] . However, the work that has focused on identifying clusters of women with BC using HRQOL measures has been somewhat limited. Several studies combined multiple cancer types, many were conducted abroad, most were cross sectional, and all had sample sizes of fewer than 500 women [17] [18] [19] [20] [21] . Using a large, population-based study of over 2000 women with BC offers an opportunity to expand upon previous HRQOL cluster analysis work and draw conclusions more generalizable to women with BC in the U.S.
The objectives of this study were to (1) employ latent profile analysis (LPA) to identify subgroups of women with BC who experienced different HRQOL patterns at 5 and 25 months after diagnosis, (2) determine patient-level characteristics associated with membership in the HRQOL subgroups, (3) assess the probability of transitioning from one subgroup to another between the two distinct phases of the BC care continuum, and, finally, (4) identify patient-level characteristics associated with transitioning from one LP to another LP between 5 and 25 months. To our knowledge, no studies have used LPA and LTA in a large, populationbased BC cohort in the U.S. to examine HRQOL pattern. The clinical meaningfulness of HRQOL subgroups will help inform and may improve targeted HRQOL management for women with BC in the U.S.
Methods

Data
We used data from the third phase of the Carolina Breast Cancer Study (CBCS-III). Through rapid case ascertainment, CBCS-III enrolled 2998 women diagnosed with incident, invasive, pathologically confirmed BC between 2008 and 2013 across 44 counties in NC [22, 23] . By oversampling young and Black women, the population-based CBCS-III cohort is 50% Black and 50% under the age of 50. CBCS-III intended to be representative of women across the state and, therefore, enrolled those in rural and urban regions, women with private, public or no insurance, and of varying income levels [22] . Demographics, lifestyle factors, and HRQOL data were first collected in-person by nurses within 9 months of BC diagnosis and at a median of 5.2 months post diagnosis (range 1.8-8.9 months) [22, 24] . At the initial interview, participants consented for researchers to abstract their medical records [22] [23] [24] . Women also completed a follow-up survey, which included additional HRQOL questionnaires at a median of 25 months post diagnosis (range 20-36 months), which is referred to as the "25-month survey." Medical record abstraction data included comorbidities and BC treatments. Pathology report data provided information regarding tumor stage and grade. This study was approved by the Institutional Review Board at the University of North Carolina at Chapel Hill.
Participants
We limited our sample to women who completed both 5-and 25-month surveys (82% of total women enrolled). Additional exclusions included women identifying as Hispanic or "other race" due to their small representation (3%), distant stage BC (3%), women who completed their initial survey more than 9 months after diagnosis (7%), and those who completed their follow-up survey more than 36 months after diagnosis (<1%). Therefore, 2142 Non-Hispanic Black and White women with Stage I-III BC were included in this study.
HRQOL measures
The Functional Assessment of Cancer Therapy for Breast Cancer (FACT-B) and Functional Assessment of Chronic Illness Therapy for Spiritual Well-Being (FACIT-SP) were used to measure HRQOL at both 5 and 25 months. The FACT-B is a BC-specific instrument with domains for physical, social, emotional, and function well-being and BC-specific concerns [25] . The FACT-B has been psychometrically validated and shown to be sensitive to changes over time in women with BC [26] . The FACIT-SP is a validated chronic disease instrument commonly used to measured spiritual well-being [26] [27] [28] . FACT-B and FACIT-SP domains are treated as continuous measures with higher scores indicating better HRQOL [26, 28, 29] . Minimally important differences (MID) or smallest differences in HRQOL that are considered meaningful to the patient or provider are 2-4 points per HRQOL domain [30] .
Independent variables
Primary predictors of HRQOL subgroup membership at 5 and 25 months reflect self-reported individual characteristics captured on the 5-month survey, including age at diagnosis, race, marital status, education, and insurance status.
Covariates
Self-reported smoking status, medical-record confirmed comorbid conditions (e.g., diabetes, chronic obstructive pulmonary disease, obesity, hypertension, heart disease), tumor stage and grade, surgery type, and receipt of radiation, chemotherapy, and Trastuzumab (Herceptin™) were included in analyses [31] .
Statistical analysis
Analyses were performed in R (Version 3.2.3) and SAS 9.3 with two-sided statistical tests and significance level of 5%.
LPA models
Using the six continuous FACT-B and FACIT-SP domains, we used the "mclust" model-based clustering package in R to implement a more generalized version of latent profile analysis (LPA) to identify clusters of women who experienced distinct HRQOL patterns [32] . Probabilistic clusters of women were grouped together as HRQOL latent profiles (LP) at 5 and 25 months post diagnosis, separately [33] [34] [35] [36] . To perform the LPA, we assumed homogeneity within and across LPs and LP separation (i.e., item-response probabilities allow for clear differentiation between LPs) [35] [36] [37] . However, we did not assume local independence, which enabled us to use a more general version of LPA [38, 39] . A combination of underlying theory, interpretability of findings, and model fit indices guided model selection and, thus, the ideal number of LPs at each time point [35] . We used the Bayesian Information Criteria (BIC) to compare fits of models with different covariance structures and number of LPs and selected the model with the lowest BIC value [35, 36] . We then calculated prevalence rates or the proportion of women with BC expected in each LP at 5 and 25 months [35, 40] . We also determined mean FACT-B and FACIT-SP scores in each LP and compared scores across LPs and to U.S. norm scores (considering both MIDs and statistical significance).
Predicting LP membership
We employed a one-step approach, which simultaneously estimates a LP model and a multinomial logit structural model to determine if patient-level characteristics were significantly associated with LP membership [41, 42] . The highest HRQOL LP served as the reference category. In this approach, we adjusted for smoking status, comorbid conditions, treatment, and tumor characteristics, which could influence HRQOL at a single time point and HRQOL changes over time [31, 43] . Variables presented in Table 1 were potential covariates for adjusted models. Before selecting which variables to include in the models, we conducted univariable analyses to determine covariates that were significantly associated with LP membership. We used a significance level of 0.05 to select relevant covariates to include in multivariable analyses.
Analysis of transition
To assess transition probabilities and to determine patient-level characteristics associated with transitioning, we estimated four separate multinomial logit models (MLMs) (one for each 5-month profile) to predict LP transitions from 5 to 25 months, adjusting for covariates presented in Table 1 [33, 40, 44] . Given the 16 possible transitions, we adjusted for multiple comparisons using Bonferroni. In these models, 25-month HRQOL LPs (four categories) were used as the outcomes. The highest HRQOL LP at 25 months was the reference category in all MLMs. We also used MLM to examine patient-level predictors of improving to a better LP and deteriorating to a worse LP from 5 to 25 months.
Results
Unadjusted
5-month LPs
We identified four HRQOL LPs at 5 months (Fig. 1) . The profiles were generally well ordered with mean overall FACT-B scores of 84.6, 102.8, 120.1, and 132.5, respectively. LP1 had the poorest HRQOL scores across all domains (up to one standard deviation below U.S. norms) and is considered the "poorest HRQOL profile." LP4 had the highest HRQOL scores across domains (one standard deviation above U.S norms) and is considered the "highest HRQOL profile." The second poorest HRQOL LP (LP2) had physical and functional well-being scores below U.S. norms, but not as low as LP1 (Fig. 1) . Differences between the two poorest HRQOL profiles exceeded MID thresholds of two points for every domain except physical well-being. As such, we refer to LP2 as the "poor physical HRQOL, but well-supported mental well-being profile." LP3 had physical and functional well-being scores above U.S norms, but below LP4. Mean differences between LP 3 and 4 were above MID thresholds for social, functional, and spiritual well-being and BC-specific concerns. LP3 had mean BCspecific concerns scores four points higher than LP2 and 7 points higher than LP1, which both well exceed the MID threshold. Therefore, we consider LP 3 the "second highest HRQOL profile." Patient prevalence rates at 5 months for LPs 1-4 are as follows: 32, 29, 28, and 11%, respectively. Over 60% of women with BC were in the two poorest HRQOL LPs during active treatment.
25-month LPs
We also identified four HRQOL profiles at 25 months (Fig. 2) . Similar to 5-month LPs, the profiles were well ordered with mean overall FACT-B scores of 86.1, 99.6, 108.6, and 122.3, respectively. As at 5 months, the poorest HRQOL LP was LP1 and the highest HRQOL LP was LP4. Scores across all domains were low for the poorest HRQOL profile, but especially in physical and functional domains, which were more than one standard deviation below U.S. norm scores. Women in the poor physical HRQOL, but better mental well-being profile (LP2) at 5 months reported mean physical and spiritual well-being scores higher than the second highest HRQOL profile at 25 months, but lower functional, social, and emotional well-being and BC-specific concerns (Fig. 2) . At 25 months, the poor physical HRQOL profile also had scores in social and emotional HRQOL below U.S. norms. The second highest HRQOL profile scores were generally high across all domains, but lower than scores in the highest HRQOL profile. The proportion of patients within each profile at 25 months for LPs 1-4 are as follows: 26, 12, 37, and 25%, respectively. More than 60% of the women with BC were in the highest HRQOL LPs at 25 months post diagnosis.
5-to 25-month transitions
Overall, mean HRQOL scores in the poorest HRQOL profile were lower at 25 months than at 5 months, but scores at 25 months were higher than 5 months in the best HRQOL profile. Compared to mean scores at 5 months, scores at 25 months in LP2 were higher for physical and functional well-being, lower for social, emotional, and spiritual domains, and remained the same for BC-specific concerns. Mean scores at 5 and 25 months for the second highest HRQOL profile were generally the same. There were 951 (44%) women who improved to a better HRQOL profile from 5 to 25 months, 864 (40%) who remained in the same profile over time, and 327 (15%) who deteriorated to a worse profile. Among women in the poorest HRQOL profile at 5 months, 52% remained in the poorest HRQOL profile at 25 months, and 48% transitioned to a higher HRQOL profile at 25 months (Table 2) . Of the women in the poor physical HRQOL, but better mental well-being profile at 5 months, 11% remained in that profile, 22% declined to the poorest HRQOL profile, and 67% transitioned to a higher HRQOL profile at 25 months. We observed the largest change in mean domainspecific scores from 5 to 25 months in the poor physical HRQOL, but better mental well-being profile. Among women in the second highest profile at 5 months, 18% declined in HRQOL to one of the two poorest HRQOL profiles, and 35% improved to the highest HRQOL profile at 25 months. Finally, among those in the highest HRQOL at 5 months most remained in the highest HRQOL profile (65%), 24% declined to LP3, and 11% to one of the two poorest HRQOL profiles at 25 months. 
Adjusted
Relevant covariates for adjusted models, which met the 0.05 threshold included race, age at diagnosis, smoking status, marital status, education, insurance status, diabetes, COPD, heart disease, hypertension, obesity, surgery, chemotherapy, Trastuzumab (Herceptin™), and stage of disease (Table 1) .
5-month LPs
Compared to the highest HRQOL LP, White race, younger age at diagnosis, being unmarried, having public or no insurance (versus private insurance), prevalence of COPD, and receiving chemotherapy were significantly associated with membership in the poorest HRQOL LP (Table 3) . Compared to the highest HRQOL profile, membership in the poor physical, but good mental well-being profile was significantly associated with younger age, COPD, obesity, and receipt of chemotherapy. Membership in the second highest profile was significantly associated with White race, higher level of education, COPD, and not receiving chemotherapy compared to membership in the highest profile.
25-month LPs
Compared to the highest HRQOL profile, membership in the poorest HRQOL profile at 25 months was significantly associated with Black race, being a current or former smoker, COPD, heart disease, obesity, receiving chemotherapy, and having more advanced stage BC (Table 4) . Membership in the poor physical, but good mental wellbeing profile was significantly associated with younger age, smoking, being unmarried, COPD, heart disease, obesity, chemotherapy, Stage 2 or 3 BC, and having public or no insurance (compared to membership in the highest HRQOL profile). Finally, relative to the highest HRQOL profile, membership in the second highest profile was significantly associated with White race, younger age at diagnosis, higher education, and prevalence of COPD.
Transitions
Prior to adjusting for multiple comparisons, there were no patient-level characteristics significantly associated with transitioning from a particular HRQOL profile to another profile from 5 to 25 months. Compared to women who improve from one HRQOL LP to a better LP or remain in the same LP, Black race aOR 1.32, 95% CI 1.02-1.72 and being a current smoker aOR 1.54, 95% CI 1.13-2.12 were significant predictors of HRQOL LP deterioration from 5 to 25 months. Compared to women who improve to a better HRQOL, the only predictor of remaining in the same HRQOL over time was having public (versus private) or no insurance aOR 1.52, 95% CI 1.18-1.96 and aOR 2.10, 95% CI 1.34-3.29, respectively.
Discussion
The objective of this study was to employ a novel, patient-centered approach to characterizing HRQOL patterns in women from a large population-based BC cohort and to determine patient-level characteristics associated with patterns. We identified four distinct HRQOL LPs at 5 and 25 months. Membership in poorer HRQOL LPs at 5 months was significantly associated with younger age, White race, lack of social support, public insurance or being uninsured, comorbid conditions (e.g., obesity, COPD), being a smoker, and more intensive BC treatment. At 25 months, membership in poorer HRQOL LPs was associated with modifiable patient-level factors such as smoking and obesity, as well as non-modifiable factors such as younger age, Black race, and prevalence of comorbid conditions. More advanced stage of BC and receipt of chemotherapy were also associated with poorer HRQOL LPs at 25 months. To our knowledge, no previous study has used LPA and LTA methods in a BC cohort to describe and characterize HRQOL patterns [40] . Traditional LPA and LTA are considered more patientcentered approaches to identifying women susceptible to poor HRQOL [35, 40] . LPA is appealing for identifying patterns within large, heterogeneous groups of individuals because it takes individual HRQOL patterns into account rather than aggregating scores across individuals [35, 36, 40] . This is a probabilistic model-based approach, which groups patients together based on probabilities rather than grouping symptoms or HRQOL scores together based on pre-determined distances [16] . Identifying subgroups of women with BC can offer clinically meaningful guidance on distinct HRQOL patterns experienced by this population [20] . For example, a previous study in pediatric oncology suggested that LPA could be used to develop prediction models that preemptively identify individuals who might be vulnerable to membership in poor HRQOL LPs so action can be taken early on in their care trajectories [16] . Furthermore, LTA might be able to help predict patients who are likely to transition to poorer HRQOL LPs as they move through the cancer continuum. This type of prediction tool could be especially relevant for women with BC who are in the BC care continuum for several years and could benefit from targeted HRQOL management. We also identified patient-level characteristics associated with membership in the 5 and 25 months LP, which offers insights for interventions wishing to target specific groups of patients who are risk for poor HRQOL. As these are non-modifiable characteristics routinely collected in clinic, these factors could be used to easily identify women who are most susceptible to membership in a poor HRQOL LP. Characteristics associated with lower HRQOL LP membership were generally similar at 5 and 25 months including younger age at diagnosis, race, comorbid conditions, and receipt of chemotherapy. However, some distinct differences that may help inform better HRQOL support exist. For example, membership in the poorest HRQOL LP at 5 months was associated with White race as well as socioeconomic factors such as lack of partner support, and insurance coverage and type. At 25 months, Black race was actually associated with membership in the poorest HRQOL profile, but no other socioeconomic factors were associated with the poorest HRQOL profile membership. Understanding which patient-level characteristics might be most associated with poor HRQOL LP membership at different phases of the BC care continuum helps inform HRQOL management strategies, which can vary over time [31] . For example, if clinicians are aware that particular characteristics are associated with worse HRQOL patterns at specific BC continuum phases, they might be better equipped to provide the necessary support for patients. Conversely, if supportive resources such as counseling or nursing support are limited, they could be targeted to the patients most in need. Furthermore, some modifiable patient factors such as obesity and smoking status were also strongly associated with membership in poorer HRQOL profiles as well as deteriorating to a worse HRQOL profile over time, and could potentially be intervened upon in order to help support HRQOL management in women with BC.
Limitations
Our study was limited to Non-Hispanic White and Black women with Stage 1-3 disease residing in North Carolina from 2008 to 2013. As such, results may not be generalizable to women of other races/ethnicities, those with advanced stage BC, and women in other states. Furthermore, given that there are not software packages developed to perform a traditional, one-step LTA, we performed an ad hoc version of this approach, limiting the generalizability of our findings. Performing separate MLMs at each time point could have yielded a different number of profiles, which could have complicated interpretation of our findings. As these methods continue to develop and evolve, it would be of interest to replicate these analyses. Finally, although we had a large sample size, when we estimated individual MLMs for each 5-month HRQOL LP in order to predict transitions, our sample sizes for each model became small, which may partially explain why we did not find statistically significant predictors of LP transitions. Future studies with larger samples of women with BC should further explore predictors of LP transitions.
Conclusions
LPA is a probabilistic model-based approach used to identify subgroups of individuals who share similar characteristics that might be associated with their HRQOL patterns [16] . By identifying women with BC who are likely to belong to poor HRQOL LPs, this approach offers a unique opportunity for women with BC to be offered targeted HRQOL support early in the BC care continuum [16] . This could potentially lead to downstream effects such as improved long-term HRQOL, greater adjuvant treatment adherence, and, ultimately, better BC outcomes (i.e., BC recurrence and survival) [21, 46, 47] . Results from this work suggest that we can potentially use routinely collected patient characteristics to help identify women at increased risk for experiencing poor HRQOL during active treatment and survivorship phases of their BC care. These findings are clinically relevant, as there is a national emphasis on patient-centered care that encourages clinicians to routinely collect and monitor HRQOL through electronic health records [48] [49] [50] [51] [52] [53] . Furthermore, patient-level characteristics such as age at diagnosis and race are regularly collected in clinic and could easily be used to identify women at risk for poor HRQOL. If these women were identified following BC diagnosis, they could be connected to mental health specialists, support groups from the onset of active treatment, nutritionists to control weight gain or loss, and physical therapists to help manage physical and functional well-being ailments following treatments. Leveraging LP membership to preemptively anticipate HRQOL needs of women with BC is in line with providing cancer care that reflects patient needs, preferences, and values.
